Apixaban for the Prevention of Latent Biological Valve Thrombosis

NCT06184113 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
166
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Clinical Hospital Centre Zagreb